Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 274, Issue 2 18-2, 1998, Pages

  Hickman Davis, Judy M ^a   Lindsey, J Russell ^a   Zhu, S ^a   Matalon, S ^a,b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UAB   (United States)

Author keywords

Mycoplasma pulmonis; Nitric oxide; Opsonophagocytosis; Peroxynitrite; Pulmonary defenses

Indexed keywords

GAMMA INTERFERON; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PROTEIN A; SURFACTANT;

ANIMAL CELL; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; LUNG ALVEOLUS MACROPHAGE; MOUSE; MYCOPLASMA PULMONIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0031935936     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1998.274.2.l270     Document Type: Article

References (20)

1. Alspaugh, J. A., and D. L. Granger. Inhibition of Cryptococcus neoformans replication by nitrogen oxide supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect. Immun. 59: 2291-2296, 1991.
2. Brunelli, L., J. P. Crow, and J. S. Beckman. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli. Arch. Biochem. Biophys. 316: 327-334, 1995.
3. Cartner, S. C., J. W. Simecka, D. E. Briles, G. H. Cassell, and J. R. Lindsey. Resistance to mycoplasmal lung disease in mice is a complex genetic trait. Infect. Immun. 64: 5326-5331, 1996.
4. Cartner, S. C., J. R. Simecka, J. R. Lindsey, G. H. Cassell, and J. K. Davis. Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response. Infect. Immun. 63: 4138-4142, 1995.
5. Chroneos, Z. C., R. Abdolrasulnia, J. A. Whitsett, W. R. Rice, and V. L. Shepherd. Purification of a cell-surface receptor for surfactant protein A. J. Biol. Chem. 271: 16375-16383, 1996.
6. Claudio, E., F. Segade, K. Wrobel, S. Ramos, and P. S. Lazo. Activation of murine macrophages by silica particles in vitro is a process independent of silica-induced cell death. Am. J. Respir. Cell Mol. Biol. 13: 547-554, 1995.
7. Davidson, M. K., J. R. Lindsey, R. F. Parker, J. G. Tully, and G. H. Cassell. Differences in virulence for mice among strains of Mycoplasma pulmonis. Infect. Immun. 56: 2156-2162, 1988.
8. 2 is associated with damaged alveolar macrophages. Am. Rev. Respir. Dis. 145: 406-411, 1992.
9. Davis, J. K., K. M. Delozier, D. K. Asa, F. C. Minion, and G. H. Cassell. Interactions between murine alveolar macrophages and Mycoplasma pulmonis in vitro. Infect. Immun. 29: 590-599, 1980.
10. Davis, J. K., R. F. Parker, H. White, D. Dziedzic, G. Taylor, M. K. Davidson, N. R. Cox, and G. H. Cassell. Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL/6N and C3He/HeN mice. Infect. Immun. 50: 647-654, 1985.
11. Denis, M. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen species. Cell. Immunol. 132: 150-157, 1991.
12. Dobbs, L. G. Pulmonary surfactant. Annu. Rev. Med. 40: 431-446, 1989.
13. Downing, J. F., R. Pasula, J. R. Wright, H. L. Twigg III, and Wiliam J. Martin II. Surfactant protein A promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 92: 4848-4852, 1995.
14. Evengard, B., K. Sandstedt, G. Bolske, R. Feinstein, I. Riesenfelt-Orn, and C. I. E. Smith. Intranasal inoculation of Mycoplasma pulmonis in mice with severe combined immunodeficiency (SCID) causes a wasting disease with grave arthritis. Clin. Exp. Immunol. 98: 388-394, 1995.
15. Faulkner, C. B., J. W. Simecka, M. K. Davidson, J. K. Davis, T. R. Schoeb, J. R. Lindsey, and M. P. Everson. Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease. Infect. Immun. 63: 4084-4090, 1995.
16. Foy, H. M. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin. Infect. Dis. 17, Suppl. 1: S37-S46, 1993.
17. Gaynor, C. D., F. X. McConnack, D. R. Voelker, S. E. McGowan, and L. S. Schlesinger. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J. Immunol. 155: 5343-5351, 1995.
18. Gil, J. C., R. C. Cedillo, B. G. Mayagoitia, and M. D. Paz. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann. Allergy 70: 23-25, 1993.
19. Gosselin, D., J. DeSanctis, M. Boule, E. Skamene, C. Matouk, and D. Radzioch. Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Psuedomonas aeruginosa. Infect. Immun. 63: 3272-3278, 1995.
20. Haagsman, H. P., T. Sargeant, P. V. Hauschka, B. J. Benson, and S. Hawgood. Binding of calcium to SP-A, a surfactant-associated protein. Biochemistry 29: 8894-8900, 1990.